[The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis]. 1989

G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova

The enzymatic, nonenzymatic and XIIa-dependent fibrinolysis was inhibited. In RA without systemic manifestations the main cause of appearance of soluble complexes of monomeric fibrins (SCMF) in the blood is a local activation of coagulation in the inflamed joint tissues. It is suggested that an increase of SCMF concentration in the blood in patients with RA is a reliable and dynamic index of the activity of the inflammatory process.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
August 1982, The Thoracic and cardiovascular surgeon,
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
February 1973, Ceskoslovenska pediatrie,
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
January 1991, Biotechnology (Reading, Mass.),
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
January 1972, Reumatologia,
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
January 1996, Seminars in thrombosis and hemostasis,
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
June 1978, Wiadomosci lekarskie (Warsaw, Poland : 1960),
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
November 1974, The American journal of physiology,
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
August 2021, Scientific reports,
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
January 1977, Transactions of the Royal Society of Tropical Medicine and Hygiene,
G A Belitskaia, and I A Palienko, and L I Shevchenko, and N E Fedorova
September 1972, Annals of the rheumatic diseases,
Copied contents to your clipboard!